1131570-15-4

Basic information

• Product Name: [N-(2-hydroxy-tert-butyl)carbamoyloxy]ethyl 2-methylpropanoate
• Synonyms: [N-(2-hydroxy-tert-butyl)carbamoyloxy]ethyl 2-methylpropanoate
• CAS NO: 1131570-15-4
• Molecular Weight: 247.291
• Mol File: 1131570-15-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [N-(2-hydroxy-tert-butyl)carbamoyloxy]ethyl 2-methylpropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: [N-(2-hydroxy-tert-butyl)carbamoyloxy]ethyl 2-methylpropanoate(1131570-15-4)
• EPA Substance Registry System: [N-(2-hydroxy-tert-butyl)carbamoyloxy]ethyl 2-methylpropanoate(1131570-15-4)

Safety Data

• Hazardous Substances Data: 1131570-15-4(Hazardous Substances Data)

Upstream product

• 860035-10-5 1-[[[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl]oxy]ethyl 2-methylpropanoate 
• 124-68-5 2-Amino-2-methyl-1-propanol 

Relevant articles and documents

EXTERNALLY MASKED NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE

Masked nitrogen-substituted and oxygen-substituted neopentyl sulfonyl ester prodrugs of acamprosate, pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In particular, acamprosate prodrugs exhibiting enhanced oral bioavailability and methods of using acamprosate prodrugs to treat neurodegenerative disorders, psychotic disorders, mood disorders, anxiety disorders, somatoform disorders, movement disorders, substance abuse disorders, binge eating disorder, cortical spreading depression related disorders, tinnitus, sleeping disorders, multiple sclerosis, and pain are disclosed.